CHILDREN'S HOSP OF PHILADELPHIA
GPC2 CARs in neuroblastoma: Mechanisms of resistance and efficacy of next-generation constructs
GPC2 CARs in neuroblastoma: Mechanisms of resistance and efficacy of next-generation constructs is a funding opportunity from CHILDREN'S HOSP OF PHILADELPHIA, up to 585133, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
PROJECT SUMMARY Children with high-risk neuroblastoma (NB) have a significant risk of treatment failure and death emphasizing the need to develop novel targeted therapies, which constitutes the long-term goal of this proposal. The proposed research focuses on the oncoprotein glypican-2 (GPC2), which is…